person · Reporting owner
Lynton Nicholas Hollmeyer
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Cardlytics, Inc.
Report date July 01, 2026 · Filed July 06, 2026
Section 16 reporting ended · disclosed 2026-07-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,942 |
Reported balance
After 2026-07-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-07-01 · Exercise / conversion · Acquired 157 · Balance 16,942 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2: Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. |
| Common StockSEC Table I · non-derivative | Direct | 18,442 |
Reported balance
After 2026-07-01 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-07-01 · Exercise / conversion · Acquired 1,500 · Balance 18,442 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. |
| Common StockSEC Table I · non-derivative | Direct | 18,754 |
Reported balance
After 2026-07-01 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-07-01 · Exercise / conversion · Acquired 312 · Balance 18,754 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. |
| Common StockSEC Table I · non-derivative | Direct | 21,504 |
Reported balance
After 2026-07-01 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2026-07-01 · Exercise / conversion · Acquired 2,750 · Balance 21,504 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. |
| Common StockSEC Table I · non-derivative | Direct | 19,353 |
Reported balance
After 2026-07-02 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2026-07-02 · Sale · Disposed 2,151 · Balance 19,353 F4: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $4.260 to $4.540, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). F3: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on July 1, 2026. The Reporting Person did not sell shares for any other purpose. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-07-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-07-01 · Exercise / conversion · Disposed 157 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2: Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. F5: 25% of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,500 |
Reported balance
After 2026-07-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-07-01 · Exercise / conversion · Disposed 1,500 · Balance 4,500 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2: Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. F6: 50% of the shares underlying the RSU award vested on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 938 |
Reported balance
After 2026-07-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-07-01 · Exercise / conversion · Disposed 312 · Balance 938 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2: Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. F6: 50% of the shares underlying the RSU award vested on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 19,250 |
Reported balance
After 2026-07-01 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-07-01 · Exercise / conversion · Disposed 2,750 · Balance 19,250 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2: Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. F7: RSU award will vest in equal amounts quarterly over a two-year period through April 1, 2028, provided that the Reporting Person remains employed by the Issuer on such vesting dates. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F2: Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split.
F3: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on July 1, 2026. The Reporting Person did not sell shares for any other purpose.
F4: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $4.260 to $4.540, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).
F5: 25% of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date.
F6: 50% of the shares underlying the RSU award vested on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates.
F7: RSU award will vest in equal amounts quarterly over a two-year period through April 1, 2028, provided that the Reporting Person remains employed by the Issuer on such vesting dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2025 Filed Apr 3, 2025 20:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 10,629 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-25-000050 · wk-form4_1743711006.xml · derivative · entry 5 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,518 Underlying: Common Stock · 10,629 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F4 · derivative.exercise_date: The RSU award was originally for 85,035 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date. F4 · derivative.expiration_date: The RSU award was originally for 85,035 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 1,578 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-25-000050 · wk-form4_1743711006.xml · nonDerivative · entry 3 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,494 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 581 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-25-000050 · wk-form4_1743711006.xml · nonDerivative · entry 2 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,916 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 10,629 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-25-000050 · wk-form4_1743711006.xml · nonDerivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| March 19, 2025 Filed Mar 22, 2025 00:53 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Unit · Derivative | 120,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-25-000038 · wk-form4_1742604806.xml · derivative · entry 2 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 120,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: 50% of the shares underlying the RSU award will vest on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates. F4 · derivative.expiration_date: 50% of the shares underlying the RSU award will vest on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates. Read SEC document |
| March 19, 2025 Filed Mar 22, 2025 00:53 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantPerformance Stock Unit · Derivative | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-25-000038 · wk-form4_1742604806.xml · derivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,000 shares Expires not disclosed F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The PSU vests in specified percentages upon achievement of specified price per share targets, provided that the Reporting Person remains employed by the Issuer on such vesting dates. F2 · derivative.expiration_date: The PSU vests in specified percentages upon achievement of specified price per share targets, provided that the Reporting Person remains employed by the Issuer on such vesting dates. Read SEC document |
| January 30, 2025 Filed Jan 31, 2025 00:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 3,377 | $3.19 | $10,776.01 |
DisclosureSEC source: 0001666071-25-000020 · wk-form4_1738282240.xml · nonDerivative · entry 2 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,706 F2 · shares: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for PSUs that were granted and vested on January 29, 2025. The Reporting Person did not sell shares for any other purpose. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $3.14 to $3.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 00:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 6,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-25-000020 · wk-form4_1738282240.xml · derivative · entry 4 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,312 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F4 · derivative.exercise_date: On January 29, 2025 the Compensation Committee of the Issuer's Board of Directors certified that a certain achievement of a milestone related to the installation of the Company's Ad Server at the Company's FI Partners was met, resulting in the immediate vesting of this award. F4 · derivative.expiration_date: On January 29, 2025 the Compensation Committee of the Issuer's Board of Directors certified that a certain achievement of a milestone related to the installation of the Company's Ad Server at the Company's FI Partners was met, resulting in the immediate vesting of this award. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 00:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantPerformance Stock Unit · Derivative | 6,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-25-000020 · wk-form4_1738282240.xml · derivative · entry 3 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,312 Underlying: Common Stock · 6,312 shares Expires not disclosed F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F4 · derivative.exercise_date: On January 29, 2025 the Compensation Committee of the Issuer's Board of Directors certified that a certain achievement of a milestone related to the installation of the Company's Ad Server at the Company's FI Partners was met, resulting in the immediate vesting of this award. F4 · derivative.expiration_date: On January 29, 2025 the Compensation Committee of the Issuer's Board of Directors certified that a certain achievement of a milestone related to the installation of the Company's Ad Server at the Company's FI Partners was met, resulting in the immediate vesting of this award. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 00:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 6,312 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-25-000020 · wk-form4_1738282240.xml · nonDerivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,083 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance stock unit ("PSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. Read SEC document |
| January 03, 2025 Filed Jan 6, 2025 22:51 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 6,464 | $3.67 | $23,703.49 |
DisclosureSEC source: 0001666071-25-000008 · wk-form4_1736203902.xml · nonDerivative · entry 4 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,771 F2 · shares: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on January 1, 2025. The Reporting Person did not sell shares for any other purpose. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $3.555 to $3.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). Read SEC document |
| January 01, 2025 Filed Jan 6, 2025 22:51 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 10,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-25-000008 · wk-form4_1736203902.xml · derivative · entry 7 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,147 Underlying: Common Stock · 10,630 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F6 · derivative.exercise_date: The RSU award was originally for 85,035 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date. F6 · derivative.expiration_date: The RSU award was originally for 85,035 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| January 01, 2025 Filed Jan 6, 2025 22:51 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 1,578 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-25-000008 · wk-form4_1736203902.xml · derivative · entry 6 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,468 Underlying: Common Stock · 1,578 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F5 · derivative.exercise_date: This RSU award was originally for 25,247 shares. Twenty-five percent (25%) of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F5 · derivative.expiration_date: This RSU award was originally for 25,247 shares. Twenty-five percent (25%) of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. Read SEC document |
| January 01, 2025 Filed Jan 6, 2025 22:51 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 582 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-25-000008 · wk-form4_1736203902.xml · derivative · entry 5 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,906 Underlying: Common Stock · 582 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F4 · derivative.exercise_date: The RSU award was originally for 9,299 shares. Twenty-five percent (25%) of the shares under this award vested on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F4 · derivative.expiration_date: The RSU award was originally for 9,299 shares. Twenty-five percent (25%) of the shares under this award vested on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. Read SEC document |
| January 01, 2025 Filed Jan 6, 2025 22:51 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 10,630 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-25-000008 · wk-form4_1736203902.xml · nonDerivative · entry 3 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| January 01, 2025 Filed Jan 6, 2025 22:51 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 1,578 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-25-000008 · wk-form4_1736203902.xml · nonDerivative · entry 2 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,605 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| January 01, 2025 Filed Jan 6, 2025 22:51 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 582 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-25-000008 · wk-form4_1736203902.xml · nonDerivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,027 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 11:07 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 5,936 | $3.09 | $18,312.56 |
DisclosureSEC source: 0001666071-24-000148 · wk-form4_1727953640.xml · nonDerivative · entry 4 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,445 F2 · shares: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on October 1, 2024. The Reporting Person did not sell shares for any other purpose. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $3.05 to $3.145, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 11:07 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 10,629 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-24-000148 · wk-form4_1727953640.xml · derivative · entry 7 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,777 Underlying: Common Stock · 10,629 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F6 · derivative.exercise_date: The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date. F6 · derivative.expiration_date: The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 11:07 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 1,578 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-24-000148 · wk-form4_1727953640.xml · derivative · entry 6 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,091 Underlying: Common Stock · 1,578 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F5 · derivative.exercise_date: This RSU award was originally for 38,222 shares. Twenty-five percent (25%) of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F5 · derivative.expiration_date: This RSU award was originally for 38,222 shares. Twenty-five percent (25%) of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 11:07 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 581 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-24-000148 · wk-form4_1727953640.xml · derivative · entry 5 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,488 Underlying: Common Stock · 581 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F4 · derivative.exercise_date: The RSU award was originally for 9,299 shares. Twenty-five percent (25%) of the shares under this award vested on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F4 · derivative.expiration_date: The RSU award was originally for 9,299 shares. Twenty-five percent (25%) of the shares under this award vested on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 11:07 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 10,629 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-24-000148 · wk-form4_1727953640.xml · nonDerivative · entry 3 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,381 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 11:07 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 1,578 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-24-000148 · wk-form4_1727953640.xml · nonDerivative · entry 2 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 11:07 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 581 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-24-000148 · wk-form4_1727953640.xml · nonDerivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,174 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| July 02, 2024 Filed Jul 2, 2024 23:13 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 5,956 | $7.95 | $47,368.07 |
DisclosureSEC source: 0001666071-24-000121 · wk-form4_1719961980.xml · nonDerivative · entry 4 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,593 F2 · shares: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on July 1, 2024. The Reporting Person did not sell shares for any other purpose. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $7.95 to $8.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 23:13 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 581 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-24-000121 · wk-form4_1719961980.xml · derivative · entry 7 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,069 Underlying: Common Stock · 581 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F6 · derivative.exercise_date: The RSU award was originally for 9,299 shares. Twenty-five percent (25%) of the shares under this award vested on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F6 · derivative.expiration_date: The RSU award was originally for 9,299 shares. Twenty-five percent (25%) of the shares under this award vested on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 23:13 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 1,578 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-24-000121 · wk-form4_1719961980.xml · derivative · entry 6 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,669 Underlying: Common Stock · 1,578 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F5 · derivative.exercise_date: This RSU award was originally for 38,222 shares. Twenty-five percent (25%) of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F5 · derivative.expiration_date: This RSU award was originally for 38,222 shares. Twenty-five percent (25%) of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 23:13 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 10,629 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-24-000121 · wk-form4_1719961980.xml · derivative · entry 5 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,406 Underlying: Common Stock · 10,629 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F4 · derivative.exercise_date: The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date. F4 · derivative.expiration_date: The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 23:13 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 581 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-24-000121 · wk-form4_1719961980.xml · nonDerivative · entry 3 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,549 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 23:13 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 1,578 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-24-000121 · wk-form4_1719961980.xml · nonDerivative · entry 2 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,968 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 23:13 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 10,629 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-24-000121 · wk-form4_1719961980.xml · nonDerivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| April 23, 2024 Filed Apr 23, 2024 23:03 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 276 | $12.76 | $3,521.21 |
DisclosureSEC source: 0001666071-24-000081 · wk-form4_1713913369.xml · nonDerivative · entry 2 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,761 F2 · shares: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on April 20, 2024. The Reporting Person did not sell shares for any other purpose. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $12.38 to $12.925, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). Read SEC document |
| April 22, 2024 Filed Apr 23, 2024 23:03 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 682 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-24-000081 · wk-form4_1713913369.xml · derivative · entry 3 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 682 Underlying: Common Stock · 682 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F4 · derivative.exercise_date: This RSU award was originally for 2,727 shares. 25% of the shares underlying the RSU award vested or will vest on each of April 20, 2022, April 20, 2023, April 20, 2024, and April 20, 2025. F4 · derivative.expiration_date: This RSU award was originally for 2,727 shares. 25% of the shares underlying the RSU award vested or will vest on each of April 20, 2022, April 20, 2023, April 20, 2024, and April 20, 2025. Read SEC document |
| April 22, 2024 Filed Apr 23, 2024 23:03 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 682 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-24-000081 · wk-form4_1713913369.xml · nonDerivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| April 02, 2024 Filed Apr 3, 2024 00:23 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 59 | $14.41 | $850.19 |
DisclosureSEC source: 0001666071-24-000058 · wk-form4_1712103783.xml · nonDerivative · entry 6 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,355 F2 · shares: Shares were sold solely to satisfy withholding tax obligations that resulted from the delivery of shares of common stock for RSUs that vested on April 1, 2024. The Reporting Person did not sell shares for any other purpose. F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $14.40 to $14.41, inclusive. Read SEC document |
| April 02, 2024 Filed Apr 3, 2024 00:23 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 12,401 | $13.69 | $169,769.69 |
DisclosureSEC source: 0001666071-24-000058 · wk-form4_1712103783.xml · nonDerivative · entry 5 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,414 F2 · shares: Shares were sold solely to satisfy withholding tax obligations that resulted from the delivery of shares of common stock for RSUs that vested on April 1, 2024. The Reporting Person did not sell shares for any other purpose. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.40 to $14.375, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) and (4). Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 00:23 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 807 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-24-000058 · wk-form4_1712103783.xml · derivative · entry 10 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 807 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F8 · derivative.exercise_date: This RSU award was originally for 3,226 shares. 25% of the RSUs award vested on each of April 1, 2021, April 1, 2022, April 1, 2023, and April 1, 2024. F8 · derivative.expiration_date: This RSU award was originally for 3,226 shares. 25% of the RSUs award vested on each of April 1, 2021, April 1, 2022, April 1, 2023, and April 1, 2024. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 00:23 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 581 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-24-000058 · wk-form4_1712103783.xml · derivative · entry 9 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,650 Underlying: Common Stock · 581 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F7 · derivative.exercise_date: The RSU award was originally for 9,299 shares. Twenty-five percent (25%) of the shares under this award vested on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F7 · derivative.expiration_date: The RSU award was originally for 9,299 shares. Twenty-five percent (25%) of the shares under this award vested on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 00:23 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-24-000058 · wk-form4_1712103783.xml · derivative · entry 8 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F6 · derivative.exercise_date: This RSU award was originally for 100,000 shares. 25% of the RSUs award vested on each of July 1, 2023, October 1, 2023, January 1, 2024 and April 1, 2024. F6 · derivative.expiration_date: This RSU award was originally for 100,000 shares. 25% of the RSUs award vested on each of July 1, 2023, October 1, 2023, January 1, 2024 and April 1, 2024. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 00:23 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 1,578 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-24-000058 · wk-form4_1712103783.xml · derivative · entry 7 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,202 Underlying: Common Stock · 1,578 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F5 · derivative.exercise_date: This RSU award was originally for 38,222 shares. Twenty-five percent (25%) of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F5 · derivative.expiration_date: This RSU award was originally for 38,222 shares. Twenty-five percent (25%) of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 00:23 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 807 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-24-000058 · wk-form4_1712103783.xml · nonDerivative · entry 4 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,815 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 00:23 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 581 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-24-000058 · wk-form4_1712103783.xml · nonDerivative · entry 3 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,008 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 00:23 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-24-000058 · wk-form4_1712103783.xml · nonDerivative · entry 2 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 00:23 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 1,578 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-24-000058 · wk-form4_1712103783.xml · nonDerivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| March 22, 2024 Filed Mar 25, 2024 11:29 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Unit · Derivative | 85,035 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-24-000049 · wk-form4_1711366170.xml · derivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,035 Underlying: Common Stock · 85,035 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2 · derivative.exercise_date: The RSUs shall vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date. F2 · derivative.expiration_date: The RSUs shall vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 00:59 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 15,620 | $7.77 | $121,367.40 |
DisclosureSEC source: 0001666071-24-000017 · wk-form4_1704329973.xml · nonDerivative · entry 4 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,849 F2 · shares: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on January 1, 2024. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $7.50 to $8.3825, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:59 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 581 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-24-000017 · wk-form4_1704329973.xml · derivative · entry 7 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,231 Underlying: Common Stock · 581 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F6 · derivative.exercise_date: The RSU award was originally for 9,299 shares. Twenty-five percent (25%) of the shares under this award vested on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F6 · derivative.expiration_date: The RSU award was originally for 9,299 shares. Twenty-five percent (25%) of the shares under this award vested on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:59 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 1,578 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-24-000017 · wk-form4_1704329973.xml · derivative · entry 6 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,780 Underlying: Common Stock · 1,578 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F5 · derivative.exercise_date: This RSU award was originally for 38,222 shares. Twenty-five percent (25%) of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F5 · derivative.expiration_date: This RSU award was originally for 38,222 shares. Twenty-five percent (25%) of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:59 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-24-000017 · wk-form4_1704329973.xml · derivative · entry 5 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F4 · derivative.exercise_date: This RSU award was originally for 100,000 shares. 25% of the RSUs award vested on each of July 1, 2023, October 1, 2023 and January 1, 2024. An additional 25% of the RSU award shall vest on April 1, 2024, subject to the Reporting Person's continuous service with the Issuer through the vesting date. F4 · derivative.expiration_date: This RSU award was originally for 100,000 shares. 25% of the RSUs award vested on each of July 1, 2023, October 1, 2023 and January 1, 2024. An additional 25% of the RSU award shall vest on April 1, 2024, subject to the Reporting Person's continuous service with the Issuer through the vesting date. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:59 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 581 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-24-000017 · wk-form4_1704329973.xml · nonDerivative · entry 3 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,469 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.